Concepedia

Anne Pannier

AP

Statistics

Publications

5

Citations

270

H-Index

5

Active since

2004

Affiliations

Roche (Switzerland)(Current)

Anne Pannier is an author at Roche (Switzerland) specializing in pharmacology, pharmacokinetics, and medicine.

Publications per year

2004–2010

5

Publications

5

Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Chronic Kidney Disease

Iain C. Macdougall, Richard A. Robson, Sylvie Opatrná et al. · Clinical Journal of the American Society of Nephrology · 2006 · 188 citations

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacokinetic and Pharmacodynamic Properties of Methoxy Polyethylene Glycol‐Epoetin Beta Are Unaffected by the Site of Subcutaneous Administration<sup>1</sup>

Steven Fishbane, Anne Pannier, Xavier Liogier et al. · The Journal of Clinical Pharmacology · 2007 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +13

Population Pharmacokinetic/Pharmacodynamic Model for C.E.R.A. in Both ESA‐Naïve and ESA‐Treated Chronic Kidney Disease Patients With Renal Anemia

Pascal Chanu, Ronald Gieschke, Jean‐Eric Charoin et al. · The Journal of Clinical Pharmacology · 2010 · 22 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa

Anne Pannier, Paul Jordan, Frank C. Dougherty et al. · Current Medical Research and Opinion · 2007 · 14 citations

Nursing, Pharmacology, Pharmacotherapy +16

CERA (Continuous Erythropoiesis Receptor Activator): Dose-response, pharmacokinetics and tolerability in phase I multiple ascending dose studies

Frank C. Dougherty, Bruno Reigner, Paul Jordan et al. · Journal of Clinical Oncology · 2004 · 13 citations

Medicine, Pharmacokinetics, Pharmacology +10

1–5 of 5